What's Hot

    Introducing CleverAutomations: Ready-to-Use Automation Journeys for Recurring Revenue Growth

    September 21, 2023

    IKEA is Shocking Norwegians With Alternative Motives to Buy Their Furniture

    September 20, 2023

    Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery

    September 19, 2023
    Facebook X (Twitter) Instagram
    Trending
    • Introducing CleverAutomations: Ready-to-Use Automation Journeys for Recurring Revenue Growth
    • IKEA is Shocking Norwegians With Alternative Motives to Buy Their Furniture
    • Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
    • United Arab Emirates Becomes First Country to Hold Fully Digital Elections With Scytl
    • CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation
    • TIME100 AI List’s Sougwen Chung: New AI Art Exhibition, HOFA
    • Better Worlds & AMM Announce Winners of the CultureTech Art & Music Challenge
    • HFR Supplies Private 5G for the ‘Metaverse-Based Industrial Advancement Project’ in Sacheon Aviation Complex
    • Home
    • Contact Us
    South Africa GazetteSouth Africa Gazette
    Friday, September 22
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    South Africa GazetteSouth Africa Gazette
    Home » $1.5 billion WHO campaign aims to prevent bacterial meningitis in Africa

    $1.5 billion WHO campaign aims to prevent bacterial meningitis in Africa

    September 9, 2022
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The World Health Organization (WHO) has announced it will launch a $1.5 billion campaign to eliminate outbreaks of bacterial meningitis across Africa by 2030. In the wake of the COVID-19 pandemic, more than 50 million children in Africa have not yet received their meningitis vaccinations, raising fears of a resurgence of the deadly disease. A “next generation” vaccine against meningitis will be rolled out in 26 African countries most affected by the disease in a “race against time,” WHO regional director for Africa Matshidiso Moeti said. The WHO hopes to authorize the vaccine by the first quarter of 2023, so donors can buy it for Africa.

    $1.5 billion WHO campaign aims to prevent bacterial meningitis in AfricaAccording to Moeti, the vaccine has been shown to be safe and effective against multiple types of meningitis in clinical trials. Next year, it could be rolled out and used to create widespread drives until 2030. By then, the WHO hopes to have stopped outbreaks of bacterial meningitis on the continent of 54 countries and 1.3 billion people. According to the WHO, the shot could save more than 140,000 people every year – but that depends on availability and the ability of health officials to administer it. The COVID-19 pandemic and attendant restrictions have left “hundreds of millions” of Africans at risk, according to Moeti, despite no new cases of meningitis A on the continent in the past five years.

    During a weekly briefing, she said that meningitis had “somewhat dropped off the radar” but that COVID-19 could threaten some of the gains made in the past. According to WHO reports, meningitis control activities declined by 50% in 2020 in comparison to 2019 before the COVID-19 outbreak in Africa, although there was a “slight improvement” in 2021. According to WHO, meningitis causes serious infections of the membranes protecting the brain and spinal cord. It is caused by “many different pathogens,” including fungi, viruses, and bacteria.

    According to the WHO, bacterial meningitis is the most deadly. During close and prolonged contact such as kissing, sneezing, coughing or living close to an infected person, carriers can spread the disease through respiratory or throat fluids. In the event of serious meningitis, it is likely to lead to epidemics and lead to death within 24 hours. In addition, the WHO states that one in five patients will have disabilities for the rest of their lives after they have been infected. The WHO notes that symptoms include headaches, stiff necks, fever, nausea or vomiting, feeling drowsy or confused, or a sudden dislike of bright light.

    Keep Reading

    New research warns of liver risk from daily soda consumption

    Sheesha cafes are a lethal mix of health risks and idle talk

    Blue Zone centenarians’ longevity linked to high-carb diet

    Cholesterol – the silent killer and Its Impact on hearing

    The dynamic science behind the static plank

    WHO raises alert on EG.5 Coronavirus variant in the US and UK

    Latest News

    From India to Brazil, leadership transition marks G20 Summit’s conclusion

    September 11, 2023

    African Union Inducted into G20 on India’s Initiative

    September 9, 2023

    Biden and Modi cement ties as India ascends global stage

    September 9, 2023

    UN calls for greater female representation in police forces worldwide

    September 8, 2023

    Digital work revolution sees the world’s gig economy expand by 12 percent

    September 8, 2023

    AI drives MENA Newswire’s entry into Saudi digital media

    September 8, 2023

    ASEAN Summit in Jakarta sees PM Modi advocating India’s growing global impact

    September 7, 2023
    © 2022 South Africa Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.